Literature DB >> 31536808

Comparative proteomic analysis of trypomastigotes from Trypanosoma cruzi strains with different pathogenicity.

Alfonso Herreros-Cabello1, Francisco Callejas-Hernández1, Manuel Fresno2, Núria Gironès3.   

Abstract

Chagas disease, caused by the parasite Trypanosoma cruzi, is one of the most neglected diseases in Latin America, being currently a global health problem. Its immunopathogenesis is still quite unknown. Moreover, there are important differences in pathogenicity between some different T. cruzi strains. For example, in mice, Y strain produces a high acute lethality while VFRA remains in the host mostly in a chronic manner. Comparative proteomic studies between T. cruzi strains represent a complement for transcriptomics and may allow the detection of relevant factors or distinctive functions. Here for the first time, we compared the proteome of trypomastigotes from 2 strains, Y and VFRA, analyzed by mass spectrometry. Gene ontology analysis were used to display similarities or differences in cellular components, biological processes and molecular functions. Also, we performed metabolic pathways enrichment analysis to detect the most relevant pathways in each strain. Although in general they have similar profiles in the different ontology groups, there were some particular interesting differences. Moreover, there were around 10% of different proteins between Y and VFRA strains, that were shared by other T. cruzi strains or protozoan species. They displayed many common enriched metabolic pathways but some others were uniquely enriched in one strain. Thus, we detected enriched antioxidant defenses in VFRA that could correlate with its ability to induce a chronic infection in mice controlling ROS production, while the Y strain revealed a great enrichment of pathways related with nucleotides and protein production, that could fit with its high parasite replication and lethality. In summary, Y and VFRA strains displayed comparable proteomes with some particular distinctions that could contribute to understand their different biological behaviors.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chagas disease; Enriched metabolic pathways; Gene ontology; Proteome; Trypanosoma cruzi; Trypomastigote

Mesh:

Substances:

Year:  2019        PMID: 31536808     DOI: 10.1016/j.meegid.2019.104041

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  3 in total

Review 1.  Trypanosoma Cruzi Genome: Organization, Multi-Gene Families, Transcription, and Biological Implications.

Authors:  Alfonso Herreros-Cabello; Francisco Callejas-Hernández; Núria Gironès; Manuel Fresno
Journal:  Genes (Basel)       Date:  2020-10-14       Impact factor: 4.096

2.  The Complete Mitochondrial DNA of Trypanosoma cruzi: Maxicircles and Minicircles.

Authors:  Francisco Callejas-Hernández; Alfonso Herreros-Cabello; Javier Del Moral-Salmoral; Manuel Fresno; Núria Gironès
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

3.  Interaction of Signaling Lymphocytic Activation Molecule Family 1 (SLAMF1) receptor with Trypanosoma cruzi is strain-dependent and affects NADPH oxidase expression and activity.

Authors:  Cristina Poveda; Alfonso Herreros-Cabello; Francisco Callejas-Hernández; Jesús Osuna-Pérez; María C Maza; Carlos Chillón-Marinas; Jossela Calderón; Konstantinos Stamatakis; Manuel Fresno; Núria Gironès
Journal:  PLoS Negl Trop Dis       Date:  2020-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.